{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:21:15Z","timestamp":1793146875074,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.chest.2023.10.043","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T04:33:57Z","timestamp":1698986037000},"page":"800-809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Longitudinal Effects of Elexacaftor\/Tezacaftor\/Ivacaftor"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7478-8414","authenticated-orcid":false,"given":"Sonia","family":"Graziano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Boldrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-0272","authenticated-orcid":false,"given":"Gaia Romana","family":"Pellicano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2746-4086","authenticated-orcid":false,"given":"Francesco","family":"Milo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Majo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7677-6775","authenticated-orcid":false,"given":"Luca","family":"Cristiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza","family":"Montemitro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-791X","authenticated-orcid":false,"given":"Federico","family":"Alghisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7711-5672","authenticated-orcid":false,"given":"Renato","family":"Cutrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro Giovanni","family":"Fiocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4139-6983","authenticated-orcid":false,"given":"Alexandra","family":"Quittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Tabarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.chest.2023.10.043_bib1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"10212","key":"10.1016\/j.chest.2023.10.043_bib2","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"4 suppl 2","key":"10.1016\/j.chest.2023.10.043_bib3","first-page":"1","article-title":"Registro italiano Fibrosi Cistica (RIFC). Rapporto 2019-2020","volume":"46","author":"Campagna","year":"2022","journal-title":"Epidemiol Prev"},{"issue":"1","key":"10.1016\/j.chest.2023.10.043_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcf.2022.08.018","article-title":"Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor\/tezacaftor\/ivacaftor","volume":"22","author":"Fajac","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.chest.2023.10.043_bib5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/cts.12764","article-title":"Clinical trial generalizability assessment in the big data era: a review","volume":"13","author":"He","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.chest.2023.10.043_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106147","article-title":"Rates of depression and anxiety in Italian patients with cystic fibrosis and parent caregivers: implementation of the Mental Health Guidelines","volume":"172","author":"Graziano","year":"2020","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.chest.2023.10.043_bib7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/thoraxjnl-2014-205983","article-title":"Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries","volume":"69","author":"Quittner","year":"2014","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.chest.2023.10.043_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcf.2021.10.002","article-title":"Mental status changes during elexacaftor\/tezacaftor\/ivacaftor therapy","volume":"21","author":"Heo","year":"2022","journal-title":"J\u00a0Cyst Fibros"},{"issue":"6","key":"10.1016\/j.chest.2023.10.043_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jcf.2022.05.001","article-title":"Dose adjustments of elexacaftor\/tezacaftor\/ivacaftor in response to mental health side effects in adults with cystic fibrosis","volume":"21","author":"Spoletini","year":"2022","journal-title":"J\u00a0Cyst Fibros"},{"issue":"1","key":"10.1016\/j.chest.2023.10.043_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/jcm10010023","article-title":"Real-world safety of CFTR modulators in the treatment of cystic fibrosis: a systematic review","volume":"10","author":"Dagenais","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.chest.2023.10.043_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.psym.2017.04.001","article-title":"Cystic fibrosis transmembrane regulator modulators: implications for the management of depression and anxiety in cystic fibrosis","volume":"58","author":"Talwalkar","year":"2017","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.chest.2023.10.043_bib12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2017.05.008","article-title":"Worsening anxiety and depression after initiation of lumacaftor\/ivacaftor combination therapy in adolescent females with cystic fibrosis","volume":"16","author":"McKinzie","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"issue":"6","key":"10.1016\/j.chest.2023.10.043_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.psym.2020.06.021","article-title":"Trikafta and psychopathology in cystic fibrosis: a case report","volume":"61","author":"Tindell","year":"2020","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.chest.2023.10.043_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jcf.2023.01.015","article-title":"Suicide attempts in adolescents with cystic fibrosis on elexacaftor\/tezacaftor\/ivacaftor therapy","volume":"22","author":"Arslan","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.chest.2023.10.043_bib15","first-page":"S453","article-title":"Psychometric analyses of a new GI symptom tracker for cystic fibrosis","volume":"52","author":"Quittner","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.chest.2023.10.043_bib16","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/S1569-1993(19)30711-8","article-title":"Italian translation of Gastrointestinal (GI) Symptom Tracker in patients with cystic fibrosis","volume":"18","author":"Graziano","year":"2019","journal-title":"J\u00a0Cystic Fibrosis"},{"key":"10.1016\/j.chest.2023.10.043_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221144211","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on depression and anxiety in cystic fibrosis","volume":"16","author":"Zhang","year":"2022","journal-title":"Ther Adv Respir Dis"},{"issue":"9","key":"10.1016\/j.chest.2023.10.043_bib18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.chest.2023.10.043_bib19","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","year":"2013"},{"issue":"10","key":"10.1016\/j.chest.2023.10.043_bib20","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A\u00a0brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.chest.2023.10.043_bib21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/1352458517690821","article-title":"Rudick R; and the Multiple Sclerosis Outcome Assessments Consortium. Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis","volume":"23","author":"Benedict","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.chest.2023.10.043_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102950","article-title":"The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: lexical access speed, memory, and information processing speed independently contribute to SDMT performance","volume":"51","author":"Sandry","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.chest.2023.10.043_bib23","series-title":"Symbol Digits Modalities Test","author":"Smith","year":"1982"},{"issue":"7","key":"10.1016\/j.chest.2023.10.043_bib24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s11136-011-0091-5","article-title":"Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample","volume":"21","author":"Quittner","year":"2012","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.chest.2023.10.043_bib25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.mcna.2022.07.005","article-title":"Cystic fibrosis: highly effective targeted therapeutics and the impact on sex and racial disparities","volume":"106","author":"Montemayor","year":"2022","journal-title":"Med Clin North Am"},{"issue":"2","key":"10.1016\/j.chest.2023.10.043_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.chest.2023.10.043_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2021.101556","article-title":"Improving sleep quality leads to better mental health: a meta-analysis of randomised controlled trials","volume":"60","author":"Scott","year":"2021","journal-title":"Sleep Med Rev"},{"issue":"1","key":"10.1016\/j.chest.2023.10.043_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcf.2022.10.002","article-title":"Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis","volume":"22","author":"Southern","year":"2023","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.chest.2023.10.043_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.msard.2018.01.014","article-title":"Symbol Digit Modalities Test adaptation for magnetic resonance imaging environment: a systematic review and meta-analysis","volume":"20","author":"Silva","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"10.1016\/j.chest.2023.10.043_bib30","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1369\/jhc.2009.953455","article-title":"Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the human brain","volume":"57","author":"Guo","year":"2009","journal-title":"J\u00a0Histochem Cytochem"},{"issue":"9","key":"10.1016\/j.chest.2023.10.043_bib31","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/ppul.26527","article-title":"Positive and negative impacts of elexacaftor\/tezacaftor\/ivacaftor: healthcare providers\u2019 observations across US centers","volume":"58","author":"Bathgate","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.chest.2023.10.043_bib32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1513\/AnnalsATS.202010-1336SD","article-title":"Evaluating the impact of stopping chronic therapies after modulator drug therapy in cystic fibrosis: the SIMPLIFY Clinical Trial Study Design","volume":"18","author":"Mayer-Hamblett","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.chest.2023.10.043_bib33","unstructured":"Cystic Fibrosis Trust. CF STORM; A trial to assess change in respiratory function for people with cystic fibrosis on triple combination therapy (Kaftrio\u2122) after rationalisation of nebulised mucoactive therapies. TT005796. Cystic Fibrosis Trust website; 2022. Updated May 12, 2022. https:\/\/www.cysticfibrosis.org.uk\/get-involved\/clinical-trials\/trialstracker\/138613"},{"key":"10.1016\/j.chest.2023.10.043_bib34","series-title":"Promoting Adherence to Medical Treatment in Childhood Chronic Illness: Interventions and Methods","article-title":"Adherence to medical treatments in adolescents with cystic fibrosis: the development and evaluation of family-based interventions","author":"Quittner","year":"2000"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223056891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223056891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T21:08:23Z","timestamp":1715116103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369223056891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0012369223056891"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2023.10.043","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Effects of Elexacaftor\/Tezacaftor\/Ivacaftor","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2023.10.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}